Advertisement
Screener

ENANTA PHARMACEUTICALS, INC (ENTA) Deferred Tax Assets, Unrealized Losses on Trading Securities

1.6 / 5 stars · 38/120 Roast Me

ENANTA PHARMACEUTICALS, INC Deferred Tax Assets, Unrealized Losses on Trading Securities

ENANTA PHARMACEUTICALS, INC (ENTA) had Deferred Tax Assets, Unrealized Losses on Trading Securities of $0 as of 2024-09-30, per its 10-K filed 2024-11-27.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities · last filed 2024-11-27

  • 2024-09-30: Deferred Tax Assets, Unrealized Losses on Trading Securities $0.00.
  • 2023-09-30: Deferred Tax Assets, Unrealized Losses on Trading Securities $189.00K.
  • 2022-09-30: Deferred Tax Assets, Unrealized Losses on Trading Securities $794.00K.
Period endDeferred Tax Assets, Unrealized Losses on Trading Securities
2024-09-30$0.00
10-K · filed 2024-11-27
2023-09-30$189.00K
10-K · filed 2024-11-27
2022-09-30$794.00K
10-K · filed 2023-11-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Rezolute, Inc. (RZLT)United States$0.382B-6.45
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63